ritanserin has been researched along with n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-n-(2-pyridinyl)cyclohexanecarboxamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ennis, C; Khawaja, X; Minchin, MC | 1 |
Chen, Z; Collier, T; Fu, H; Liang, SH; Rong, J; Zhou, J | 1 |
1 review(s) available for ritanserin and n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-n-(2-pyridinyl)cyclohexanecarboxamide
Article | Year |
---|---|
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.
Topics: Brain; Humans; Ligands; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Serotonin | 2022 |
1 other study(ies) available for ritanserin and n-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-n-(2-pyridinyl)cyclohexanecarboxamide
Article | Year |
---|---|
Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding, Competitive; CHO Cells; Cricetinae; Hippocampus; Humans; In Vitro Techniques; Kinetics; Piperazines; Pyridines; Radioligand Assay; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Recombinant Proteins; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 1997 |